US Patent 11919921 Galactoside inhibitor of galectins
Patent 11919921 was granted and assigned to Galecto Biotech on March, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11919921 Galactoside inhibitor of galectins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.